346 related articles for article (PubMed ID: 27272560)
1. Potential Role of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Regulation of Matrix Metalloproteinases (MMPs) Expression in Periodontal Diseases.
Liu N; Zhou B; Zhu G
Med Sci Monit; 2016 Jun; 22():1936-8. PubMed ID: 27272560
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinases-2, -9 and reversion-inducing cysteine-rich protein with Kazal motifs in gingiva in periodontal health and disease.
Liu N; Cao Y; Zhu G
Arch Oral Biol; 2017 Mar; 75():62-67. PubMed ID: 28043014
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK.
Siddesha JM; Valente AJ; Sakamuri SS; Yoshida T; Gardner JD; Somanna N; Takahashi C; Noda M; Chandrasekar B
J Mol Cell Cardiol; 2013 Dec; 65():9-18. PubMed ID: 24095877
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the inhibiting activity of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) on matrix metalloproteinases.
Mendes SR; Amo-Maestro LD; Marino-Puertas L; Diego I; Goulas T; Gomis-Rüth FX
Sci Rep; 2020 Apr; 10(1):6317. PubMed ID: 32286475
[TBL] [Abstract][Full Text] [Related]
5. RECK, a novel matrix metalloproteinase regulator.
Meng N; Li Y; Zhang H; Sun XF
Histol Histopathol; 2008 Aug; 23(8):1003-10. PubMed ID: 18498076
[TBL] [Abstract][Full Text] [Related]
6. The RECK gene and biological malignancy--its significance in angiogenesis and inhibition of matrix metalloproteinases.
Alexius-Lindgren M; Andersson E; Lindstedt I; Engström W
Anticancer Res; 2014 Aug; 34(8):3867-73. PubMed ID: 25075007
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of reversion-inducing cysteine-rich protein with Kazal motifs in malignant melanoma: inverse correlation with membrane-type 1-matrix metalloproteinase and tissue inhibitor of metalloproteinase 2.
Jacomasso T; Trombetta-Lima M; Sogayar MC; Winnischofer SM
Melanoma Res; 2014 Feb; 24(1):32-9. PubMed ID: 24335752
[TBL] [Abstract][Full Text] [Related]
8. Variations on brain microglial gene expression of MMPs, RECK, and TIMPs in inflammatory and non-inflammatory diseases in dogs.
Stein VM; Puff C; Genini S; Contioso VB; Baumgärtner W; Tipold A
Vet Immunol Immunopathol; 2011 Nov; 144(1-2):17-26. PubMed ID: 21802747
[TBL] [Abstract][Full Text] [Related]
9. Reversion inducing cysteine rich protein with Kazal motifs and cardiovascular diseases: The RECKlessness of adverse remodeling.
Russell JJ; Grisanti LA; Brown SM; Bailey CA; Bender SB; Chandrasekar B
Cell Signal; 2021 Jul; 83():109993. PubMed ID: 33781845
[TBL] [Abstract][Full Text] [Related]
10. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.
Figueira RC; Gomes LR; Neto JS; Silva FC; Silva ID; Sogayar MC
BMC Cancer; 2009 Jan; 9():20. PubMed ID: 19144199
[TBL] [Abstract][Full Text] [Related]
11. Matrix Metalloproteinases in the Periodontium-Vital in Tissue Turnover and Unfortunate in Periodontitis.
Radzki D; Negri A; Kusiak A; Obuchowski M
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474009
[TBL] [Abstract][Full Text] [Related]
12. A Hypothesis for the Role of RECK in Angiogenesis.
Gutiérrez J; Droppelmann CA; Salsoso R; Westermeier F; Toledo F; Salomon C; Sanhueza C; Pardo F; Leiva A; Sobrevia L
Curr Vasc Pharmacol; 2016; 14(1):106-15. PubMed ID: 26463982
[TBL] [Abstract][Full Text] [Related]
13. RECKing MMP: relevance of reversion-inducing cysteine-rich protein with kazal motifs as a prognostic marker and therapeutic target for cancer (a review).
Nagini S
Anticancer Agents Med Chem; 2012 Sep; 12(7):718-25. PubMed ID: 22292753
[TBL] [Abstract][Full Text] [Related]
14. Reversion-inducing-cysteine-rich protein with Kazal motif is involved in intimal hyperplasia in carotid arteries: a new insight in the prevention of restenosis after vascular angioplasty.
Liu J; Chi D; Lu H; Zhang T; Yamakawa T
Ann Vasc Surg; 2015 Aug; 29(6):1293-9. PubMed ID: 26004948
[TBL] [Abstract][Full Text] [Related]
15. Spatial analysis of RECK, MT1-MMP, and TIMP-2 proteins during early Xenopus laevis development.
Willson JA; Damjanovski S
Gene Expr Patterns; 2019 Dec; 34():119066. PubMed ID: 31352120
[TBL] [Abstract][Full Text] [Related]
16. The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) interacts with membrane type 1 matrix metalloproteinase and CD13/aminopeptidase N and modulates their endocytic pathways.
Miki T; Takegami Y; Okawa K; Muraguchi T; Noda M; Takahashi C
J Biol Chem; 2007 Apr; 282(16):12341-52. PubMed ID: 17329256
[TBL] [Abstract][Full Text] [Related]
17. RECK (reversion-inducing cysteine-rich protein with Kazal motifs) regulates migration, differentiation and Wnt/β-catenin signaling in human mesenchymal stem cells.
Mahl C; Egea V; Megens RT; Pitsch T; Santovito D; Weber C; Ries C
Cell Mol Life Sci; 2016 Apr; 73(7):1489-501. PubMed ID: 26459448
[TBL] [Abstract][Full Text] [Related]
18. Solasodine inhibits invasion of human lung cancer cell through downregulation of miR-21 and MMPs expression.
Shen KH; Hung JH; Chang CW; Weng YT; Wu MJ; Chen PS
Chem Biol Interact; 2017 Apr; 268():129-135. PubMed ID: 28283413
[TBL] [Abstract][Full Text] [Related]
19. Recent Updates on the Therapeutic Prospects of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Liver Injuries.
Palladini G; Di Pasqua LG; Croce AC; Ferrigno A; Vairetti M
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139236
[TBL] [Abstract][Full Text] [Related]
20. Differential expressions of matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs and their endogenous inhibitors among histologic subtypes of lung cancers.
Hida Y; Hamada J
Anticancer Agents Med Chem; 2012 Sep; 12(7):744-52. PubMed ID: 22292754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
